​
​

Janux Therapeutics (JANX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Janux Therapeutics Revenue Highlights

Latest Revenue (Y)

$8.08M

Latest Revenue (Q)

$8.90M

Janux Therapeutics Revenue by Period

Janux Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$8.08M-6.14%
2022-12-31$8.61M136.79%
2021-12-31$3.64M100.00%
2020-12-31-100.00%
2019-12-31--

Janux Therapeutics generated $8.08M in revenue during NA 2023, up -6.14% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Janux Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30$8.90M610.62%
2024-03-31$1.25M-49.13%
2023-12-31$2.46M-2.22%
2023-09-30$2.52M138.13%
2023-06-30$1.06M-48.39%
2023-03-31$2.05M-28.01%
2022-12-31$2.85M56.92%
2022-09-30$1.81M-23.34%
2022-06-30$2.37M48.84%
2022-03-31$1.59M-1.67%
2021-12-31$1.62M39.43%
2021-09-30$1.16M140.46%
2021-06-30$482.00K26.84%
2021-03-31$380.00K100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Janux Therapeutics generated $8.90M in revenue during Q2 2024, up 610.62% compared to the previous quarter, and up 434.42% compared to the same period a year ago.

Janux Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
HRMYHarmony Biosciences$582.02M$186.04M
FENCFennec Pharmaceuticals$21.64M$6.97M
ADAGAdagene$18.11M$833.34K
JANXJanux Therapeutics$8.08M$8.90M
MOLNMolecular Partners$7.04M$2.74M
MNOVMediciNova$1.00M-
KROSKeros Therapeutics$151.00K$37.00K
ANEBAnebulo Pharmaceuticals--
RZLTRezolute--
ANTXAN2 Therapeutics--
AVTEAerovate Therapeutics--
CYTCyteir Therapeutics--
ELYMEliem Therapeutics--
ACRVAcrivon Therapeutics--
MLYSMineralys Therapeutics--
EWTXEdgewise Therapeutics--
CSBRChampions Oncology--

JANX Revenue FAQ

What is Janux Therapeutics’s yearly revenue?

Janux Therapeutics's yearly revenue for 2023 was $8.08M, representing a decrease of -6.14% compared to 2022. The company's yearly revenue for 2022 was $8.61M, representing an increase of 136.79% compared to 2021. JANX's yearly revenue for 2021 was $3.64M, representing an increase of 100.00% compared to 2020.

What is Janux Therapeutics’s quarterly revenue?

Janux Therapeutics's quarterly revenue for Q2 2024 was $8.9M, a 610.62% increase from the previous quarter (Q1 2024), and a 741.72% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1.25M, a -49.13% decrease from the previous quarter (Q4 2023), and a -38.87% decrease year-over-year (Q1 2023). JANX's quarterly revenue for Q4 2023 was $2.46M, a -2.22% decrease from the previous quarter (Q3 2023), and a -13.50% decrease year-over-year (Q4 2022).

What is Janux Therapeutics’s revenue growth rate?

Janux Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 122.24%, and for the last 5 years (2019-2023) was 0%.